Resmed Inc. buy Mizuho
Start price
26.01.24
/
50%
€175.35
Target price
26.01.25
€179.54
Performance (%)
35.33%
End price
27.01.25
€237.30
Summary
This prediction ended on 27.01.25 with a price of €237.30. With a performance of 35.33% the BUY prediction by Mizuho was a big success. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.282% | 0.282% | 3.519% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Mizuho from $180.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten